Minerva Neurosciences, Inc.

NERV · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.3B · 7 employees
207
SEC Filings
$3.46
Close 2026-09-17
7
Employees

Business Summary

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its lead product candidate, roluperidone, is being developed for the treatment of negative symptoms of schizophrenia. The company received a Complete Response Letter from the FDA in February 2024 for its NDA for roluperidone and is planning a confirmatory Phase 3 trial (C19).

Latest Stock Quote

NERV 2026-09-17 $3.46 O:$3.56 H:$3.635 L:$3.44 Vol:0.2M VWAP:$3.5032
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-21

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-112025-12-310001193125-26-101117EDGAR82K words
2025-02-252024-12-310000950170-25-026055EDGAR79K words
2024-02-222023-12-310000950170-24-018392EDGAR80K words
2023-03-082022-12-310000950170-23-006577EDGAR79K words
2022-03-012021-12-310001564590-22-007853EDGAR—
2021-03-082020-12-310001564590-21-011340EDGAR—
2020-03-092019-12-310001564590-20-009243EDGAR—
2019-03-122018-12-310001564590-19-007246EDGAR—
2018-03-122017-12-310001564590-18-005224EDGAR—
2017-03-132016-12-310001564590-17-004048EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-072026-06-300001193125-26-339171EDGAR23K words
2025-11-052025-09-300001193125-25-265685EDGAR20K words
2025-08-142025-06-300000950170-25-108840EDGAR19K words
2025-05-132025-03-310000950170-25-069780EDGAR16K words
2024-11-052024-09-300000950170-24-121063EDGAR20K words
2024-08-062024-06-300000950170-24-091195EDGAR19K words
2024-05-012024-03-310000950170-24-050883EDGAR18K words
2023-11-072023-09-300000950170-23-059747EDGAR28K words
2023-08-012023-06-300000950170-23-036159EDGAR27K words
2023-05-152023-03-310000950170-23-021947EDGAR22K words
2022-11-092022-09-300000950170-22-023496EDGAR20K words
2022-08-092022-06-300000950170-22-015754EDGAR20K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-120001193125-26-346817EDGAR1K words
2026-08-070001193125-26-339147EDGAR4K words
2026-04-060001193125-26-143986EDGAR1K words
2026-04-020001193125-26-140148EDGAR1K words
2026-03-110001193125-26-101074EDGAR5K words
2026-02-030001193125-26-034538EDGAR1K words
2025-12-220001193125-25-328715EDGAR16K words
2025-11-190001193125-25-287048EDGAR1K words
2025-10-220001193125-25-245552EDGAR2K words
2025-03-190001193125-25-057901EDGAR1K words

207 total filings indexed. 175 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

central-nervous-system-disorders schizophrenia-treatment psychiatry/neuroscience-pharmaceuticals

Company Identity

CIK0001598646
TickerNERV
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedMA
Websitehttps://www.minervaneurosciences.com
Listed2014-07-01

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 513f201ef3314bdbd561d0fb5957fc636ef935bff2737ea87c01fc6d78cb1e1f
parent: 71d051bb34ce4732d9565133a76c4e041e280904a07dc78873b91f58a6ef7bba
content hash: d69c616c00eedc872d327f678341fc65ba3d79cbee3524b3b619f0f95ac18028
signed: 2026-09-30T19:02:31.438Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up NERV using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on NERV, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/NERV (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.